"We are pleased that Dr. Sun has joined our research team at this exciting time in our company's growth," said Dr. Lee Bulla, the Company's founder and CEO. "Biological Targets' recent developments in insecticide target identification and validation has competitively positioned our company in the pesticide industry.  Certainly, Dr. Sun's expertise in bioinformatics  will not only enhance our molecular target discovery program but our functional genomics and proteomics activities as well,” stated Dr. Bulla.       

Dr. Sun has eight years of experience in database implementation and management, data mining, computational modeling and simulation, evolutionary design, genetic algorithms and artificial intelligence. Before joining Biological Targets, she was a research fellow at the Cleveland Clinic Foundation, Cleveland, Ohio.    

Biological Targets is a new life science company that is developing biotechnological products for agriculture, medicine and the environment.  The Company offers novel technologies and safe, environmentally friendly products in areas such as molecular targets,  biopesticides, beneficial biofilm products and products for control of biofilms and microbes.